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The Power of Persuasion 
(famous quotes)
•
 
“Advertisements contain the only truth 
to be relied on in a newspaper.”
 Thomas Jefferson
•
 
“Advertising is a racket …
 
its 
contribution to humanity is exactly 
minus zero.”
 
F. Scott Fitzgerald
Advertising Pharmaceuticals
•
 
Direct-to-consumer (DTC) advertising of Rx 
drugs is currently legal in only 2 countries 
–
 
New Zealand 
–
 
the U.S.
•
 
DTC is controversial
–
 
Report to the New Zealand Ministry of Health (2003) 
recommends “That the New Zealand government 
introduce regulations and/ or legislation to prohibit the 
advertising of prescription medicines directly to the 
public, through print and broadcast media or any 
other means.”
DTC Controversies, cont.
–
 
Europe 
•
 
July 2001:  European Commission proposal to partially lift 
DTC ban
•
 
October 2002: European Parliament rejects by a vote of 494 
to 42 the EC proposals
•
 
Opponent said that Europe was at a crossroads and had to 
decide if it wants to go down the ‘slippery slope’
 
towards 
hard-sell drug advertising as seen in the U.S.
–
 
U.S.  
•
 
“The great majority of DTC ads are for very expensive me-
 too drugs that require a lot of pushing because there is no 
good reason to think they are any better than drugs already 
on the market.”
 
Angell, The Truth About Drug Companies:  How They Deceive Us and
 
What to Do About It (2005, p. 124)
Case Study:  Advertising 
Smoking Cessation Products
•
 
Smoking cessation is a major public health 
objective
•
 
Pharmaceutical companies might be able 
to make profits and promote public health
•
 
Lessons for regulating DTC advertising
–
 
In the U.S.
–
 
In New Zealand
Outline
•
 
Background on smoking cessation
•
 
Studies of the effects of advertising
–
 
Completed study of magazine advertising 
(published in June 2007 Journal of Political Economy)
–
 
In progress study of TV advertising
•
 
Completed study of impact of U.S. 
regulations on advertising (published in 2007 
Journal of Regulatory Economics)
•
 
Directions for future work on N.Z. 
BACKGROUND ON SMOKING 
CESSATION
Smoking Cessation & Public 
Health
•
 
Smoking cessation is an important part of tobacco 
control
–
 
“Quitting smoking now greatly reduces serious risks to your 
health.”
 
–
 
U.S. Surgeon General’s warning label
–
 
Healthy People 2010 objective to cut U.S. smoking prevalence 
almost in half (to 12%) can not be met without large increases in 
smoking cessation rates (Mendez and Warner 2000)
•
 
New Zealand 
–
 
23% New Zealanders smoke; 46% Maori smoke
–
 
“Clearing the Smoke:  A 5 Year Plan for Tobacco Control in New 
Zealand 2004 –
 
2009”
–
 
New Zealand Health Strategy
Advances in Smoking Cessation
•
 
Long History of Ineffective/unpleasant Methods
–
 
April 1862 Harper’s Weekly advertises product to those 
wanting to have their “craving for tobacco cured.”
–
 
By 1956 more than 26 products and remedies nationally 
advertised including “Beat-Nic”, “Tobak-O-Stop”, and 
“Kwit-Smoke”
–
 
Other methods also used.
•
 
Rapid smoking:  smokers inhale deeply from a cigarette about 
every six seconds until they become nauseated.  
•
 
Aversion therapy:  “In one study, as the subject puffed a cigarette 
the investigator fired a .22-caliber rifle 50 times from 2 feet behind 
the subject’s head twice a week for 5 weeks.   In 4 weeks the 
subject reduced his smoking from 18 to 14 cigarettes daily and in 
the final week to 10 cigarettes daily.  The investigator claimed
 
the 
experiment a success.”
 
(Schwartz 1969)
Advances in Smoking Cessation, 
cont.
Quit Rates Odds ratio
(95% C.I.)
Zyban
 
(n=2)
 
30.5%
 
2.1 (1.5,3.0)
Nicotine nasal spray (n=3)
 
30.5
 
2.7 (1.8, 4.1)
Nortriptyline
 
(n=2)
 
30.1
 
3.2 (1.8, 5.7)
Clonidine
 
(n=5)
 
25.6
 
2.1 (1.4, 3.2)
Nicotine gum (n=13)
 
23.7
 
1.5 (1.3, 1.8)
Nicotine inhaler (n=4)
 
22.8
 
2.5 (1.7, 3.6)
Rapid smoking (n=19)
 
19.9
 
2.0 (1.1, 3.5)
Nicotine patch (n=27)
 
17.7
 
1.9 (1.7, 2.2)
MD advice to quit, alone (n=7)
 
10.2
 
1.3 (1.1,1.6)
Acupuncture (n=5)
 
8.3
 
1.1 (0.7, 1.6)
Annual quit rate (1990) 5%
(n= number of clinical trials)
Smoking Cessation Guidelines
•
 
New Zealand & U.S. published guidelines 
state that there is strong evidence for
–
 
Nicotine replacement therapies
–
 
Buproprion
–
 
Nortriptyline
–
 
Varenicline
•
 
(PHARMAC only subsidizes the nicotine 
replacement therapies)
Advertising & Smoking 
Cessation
•
 
Advertising of smoking cessation products similar to public service 
anti-smoking campaigns
•
 
1996 Great American Smokeout, sponsored by the American 
Cancer Society, in collaboration with a manufacturer of nicotine
 medications 
–
 
Estimates suggest paid advertisements from the campaign reached 122 
million adults (Burton et al. 1997)
•
 
Producer advertising has been shown to be an important source of
 health information that leads to changes in consumption of dietary fiber and fat (Ippolito
 
and Mathios
 
1990, 1995)
•
 
A growing body of evidence on the impact of DTC advertising on 
consumer demand for pharmaceutical products (Bradford and Kleit's
 review, The Elgar Companion to Health Economics, 2006)
STUDIES OF THE EFFECTS OF 
ADVERTISING
Data Overview
•
 
Collected data on magazine DTC ads
•
 
Purchased TNS data on TV DTC ads, 1996 –
 
2004
–
 
For each ad, know:  product advertised, and the time, national 
network or local station, and program on which it aired  
•
 
Individual-level data from Simmons NCS, 1997-2004
–
 
Demographics, smoking
–
 
Detailed information on what magazines they read
–
 
Detailed information on TV-watching habits 
•
 
Merge DTC ads that appeared in magazines the 
respondent reports regularly reading
•
 
Merge TV ads that appeared over the last year during 
programs or dayparts
 
the respondent reports regularly 
watching
Magazine Cessation Cigarettes PSA
Better Homes and Gardens 53 327 11
Black Enterprise 0 69 3
Business Week 5 6 4
Cosmopolitan 28 764 2
Ebony 26 307 5
Essence 2 310 5
Family Circle 13 284 11
Glamour 10 591 8
Good Housekeeping 13 0 1
Jet 14 477 1
McCall's/Rosie 0 295 0
Money 4 49 0
National Geographic 6 0 0
Newsweek 44 173 6
People 110 1352 18
Playboy 12 1160 2
Reader's Digest 63 0 2
Rollingstone 18 1030 3
Seventeen 0 0 11
Sports Illustrated 63 1354 9
TV Guide 72 804 17
Time 91 442 35
US News & World Report 30 97 2
Woman's Day 26 446 5
Vogue 0 454 0
Total 704 10790 161
Table 1 SCADS Magazine Advertising Pages of Smoking 
Cessation products, Cigarettes and Tobacco products and Anti-
smoking Public Service Announcements 1994-2002
Source: SCADS data archive

Measure of Exposure to TV Ads 
# ads seen in past 12 months
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Quit Attempt & Successful Quit by 
Quintile of Magazine Ads Exposure
Exposure
Quintile
Exposure % Quit 
Attempt 
%Success
 ful Quit
Q1(0-.75) 0.1 41.6 9.6
Q2 (.76-4.12) 2.3 45.6 9.8
Q3 (4.13-0.29) 7.2 44.0 9.8
Q4 (10.3-8.99) 14.4 44.8 9.5
Q5 (19 + ) 29.9 49.3 10.3
Quintile Exposure
range
Mean
exposure
% Quit
attempt
% Successful
quit
1 (0-134) 58.9 40.3 8.9
2 (134-285) 206.8 43.0 9.5
3 (285-475) 375.7 45.4 10.1
4 (475-797) 617.4 46.7 11.3
5 (797+) 1339.6 47.9 10.9
Quit Attempt & Successful Quit by
Quintile of TV Ads Exposure
N = 27,743 smokers
Econometric Model
Yi
 
* = γ0
 
+ γ1
 
AdExpi
 
+ Z γ2
 
+ εi
Yi
 
* = smoking behaviors
 
(quit, attempt, product)
AdExpi
 
= person i’s
 
exposure of person to 
cessation ads
Z = control variables (exposure to other smoking-
 related ads, magazine-reading and TV-watching 
habits, socio-economic characteristics, survey 
wave dummies)
Estimation Issues: Exposure 
Endogeneity
•
 
Producers target advertising → exposure varies 
systematically with observable characteristics
–
 
Problematic if producers observe characteristics the 
econometrician can’t: error term will be correlated 
with measures of ad exposure
–
 
Common (unresolved) problem: Emery et al. (2003), 
Wakefield et al. (2003) and Iizuka
 
and Jin (2005)
•
 
Consumers select magazines, TV shows →
 exposure varies systematically with 
unobservable characteristics shared with other 
readers
–
 
Problematic if unobservables
 
determine smoking 
behavior
Identification Strategy, part I
•
 
Control for socio-economic characteristics 
used to target advertising
–
 
We literally observe what producers observe
–
 
Simmons NCS website’s promotion materials 
state that their data are used by every major 
marketing firm and advertising agency in U.S.
•
 
Uses variation in exposure within 
demographic groups to identify the effect 
of exposure on smoking cessation.
Identification Strategy, part II
•
 
Exploit alternative sources of identifying variation 
•
 
In study of effect of magazine ads
–
 
Within-category variation because one person reads 
Time, another reads Newsweek, etc.
–
 
Within-magazine variation due to reading intensity
–
 
For more discussion, see June 2007 JPE
•
 
In study of TV ads
–
 
Within-daypart
 
variation because people watch 
different prime time shows, etc. 
Regression Results for Magazine 
Ads
Quit Attempts
Cessation ad exposure
 
0.0022***
 
(0.0006)
Successful Quits
Cessation ad exposure
 
0.0008**
 
(0.0003)
Product Use 
Cessation ad exposure
 
0.0008**
 
(0.0004)
Cold Turkey   
Cessation ad exposure
 
0.0014***
 
(0.0005)
Notes:  Results from Stata, probit
 
coefficients and standard errors.  All models control for 
exposure to other smoking-related ads, individual demographics, general magazine 
reading, TV habits, etc.  
Regression results for TV ads 
Quit attempt Successful quit
TV Ads 
(per 100 ads)
0.261* 
(0.143)
0. 155* 
(0.087)
* P<.10
# Cessation Ads Seen Closely Match 
# TV Shows Seen
380
400
420
440
460
480
500
520
540
age18_24 age25_34 age35_45 age45_56 age55_65 age65+
34.50
35.00
35.50
36.00
36.50
37.00
37.50
38.00
Exposure to ads
# Shows watched
Quit attempt Successful quit
Cessation ads
(per 100)
0.164 0.289* 0.147 0.184**
Anti-depression ads
(per 100)
0.449*** 0.493*
 
**
0.039 0.079
Children’s Allergy ads
(per 100)
-0.420 0.110 -.429 -0.093
Effects of Cessation Ads Exposure 
Placebo Tests
Effects of DTC advertising
•
 
We think we have robust evidence that 
magazine ads increase smoking cessation
–
 
For complete discussion, see June 2007 
Journal of Political Economy
•
 
We are not yet sure about our evidence 
that TV ads increase smoking cessation
–
 
This project is very much “work in progress”
Discussion: Private Returns to 
Magazine Ads
•
 
Suppose industry increased expenditures by $2.6 
million (10%): this would imply an increase of Mean 
Ad Exposure of 2.1 advertisements
•
 
Model implies increase cessation attempts by .45 
percentage points (from a baseline of 45 percent of 
attempters)
•
 
50 million smokers would imply 225,000 new quit 
attempts with about 80,000 using a product. 
•
 
If a typical user spends $35 implies increase in sales 
of $2.8 million
–
 
Maybe some future return from the attempts w/out 
products –
 
stages of change  
Discussion: Public Health 
Returns to Magazine Ads
•
 
Increase in Ad Expenditure increases 
exposure by the same 2.1 
advertisements↑
•
 
Model implies successful cessation 
would increase by .16 percentage 
points. 
•
 
With 50 million smokers would 
increase successful quits by 80,000. 
IMPACT OF U.S. REGULATIONS 
ON DTC ADVERTISING
U.S. Regulations on DTC 
Advertising
•
 
FDA regulates DTC advertising of Rx 
•
 
FTC regulates DTC advertising of drugs 
that are available over-the-counter (OTC)
•
 
Difference between FDA, FTC → easier 
(less costly) to advertising when product 
becomes available OTC
1992
Nicoderm Print Advertisement 1992
Surgeon 
General’s 
Warning
Lessons for regulating DTC 
advertising in the U.S.
•
 
More ads could improve public health
•
 
Less regulation
–
 
In JRE study, we estimate that if FDA had allowed all 
products to be sold OTC instead of Rx, smoking cessation 
ads in magazines would have increased by 80% 
–
 
Simply moving each product OTC one year earlier would 
have increased ads by 9% 
–
 
1997 regulatory change → expenditures on TV ads sharply ↑
•
 
More competition 
–
 
Large ‘introduction effect’:  advertise during new product launch
–
 
‘Wasteful competition’
 
= advertising for market share → profits 
dissipated but public health benefits 
–
 
We find evidence of inverted U-shape:  advertising maximized 
at 4-5 products 
IMPACT OF NEW ZEALAND 
REGULATIONS ON DTC 
ADVERTISING
Regulatory Options Under 
Consideration (as of 2006)
•
 
Option 1:  allow DTC advertising to continue, with more stringent 
regulation including mandatory pre-approval of advertisements and 
stronger penalties for non-compliant advertisements
•
 
Option 2:  allow DTC advertising but with stricter requirements than 
specified by Therapeutic Products Advertising Code, possibly 
including more explicit generic warning statements and prohibiting 
advertising new products for a set period
•
 
Option 3:  ban direct-to-consumer advertising of specific prescription 
products.  Disease-state advertisements designed to raise 
awareness about medical conditions without mentioning specific 
medicines would be allowed but regulated.
•
 
Source:  Ministry of Health (2006). Direct-to-Consumer Advertising of Prescription 
Medicines in New Zealand:  Consultation document Wellington:  Ministry of Health. 
Profit-maximizing DTC 
Advertising
•
 
In the U.S.:  1997 FDA regulatory change “allows”
 DTC ads on TV; spending  from $1 b. in 1995 to $4.2 
b. in 2005 
•
 
“Drugs that are advertised to consumers are 
predominantly new drugs used to treat chronic 
conditions.”
•
 
Of the 20 most-advertised drugs in 2005:
–
 
10 were introduced in 2000 or later
–
 
17 of the 20 advertising campaigns began within a year after 
FDA approval
•
 
Source for this slide, and the next two slides:  Donohue 
et al., N Engl
 
J. Med,
 
August 16, 2007


Figure 2B
Predicted exposure to TV advertisements for medications to treat other conditions
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How are the incentives for DTC 
advertising different in N.Z.?
•
 
PHARMAC subsidies 
•
 
High demand for subsidized products →
 high returns from advertising
–
 
Increase public sector costs
•
 
But …
Subsidized products tend to be older, less 
expensive (more cost-effective) →
Advertise un-subsidized competing products to 
increase profits
My Ideas 
•
 
In process of purchasing data on DTC 
advertising expenditures in New Zealand
–
 
"Analgesics, remedies, medicines"
–
 
Annual expenditures 1995 –
 
2007, plus Jan-
 
May 
2008
–
 
per advertiser
–
 
per product/brand
–
 
per media type
•
 
Describe patterns
•
 
Econometric analysis:  explore impact of 
PHARMAC subsidies of different products
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